123/131I-IMAZA

N/A

Report date: 2025/11/27 17:57:22

NME

Base Information

Drug Name123/131I-IMAZA

Drug Alias Name123/131I-IMAZA

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 123I +[7]

Mechanisms of ActionSteroid 11-beta-hydroxylase modulatorsCytochrome P450 11B2 modulators

TargetsCytochrome P450 11B2Steroid 11-beta-hydroxylase

Therapy Area/IndicationsAdrenocortical Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Wurzburg

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Wurzburg

Inactive CompaniesN/A

Active IndicationsAdrenocortical Carcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A